Travere Therapeutics, Inc. TVTX Business Segments — Internal personnel costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept tvtx:InternalPersonnelCostsForResearchAndDevelopment.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s business segments — internal personnel costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s business segments — internal personnel costs?
- Travere Therapeutics, Inc. (TVTX) reported business segments — internal personnel costs of $24.53M in Q1 2026.
- How has Travere Therapeutics, Inc.'s business segments — internal personnel costs changed year-over-year?
- Travere Therapeutics, Inc.'s business segments — internal personnel costs increased by 22.0% year-over-year, from $20.1M to $24.53M.
- What is the long-term trend for Travere Therapeutics, Inc.'s business segments — internal personnel costs?
- Over 3 years (2022 to 2025), Travere Therapeutics, Inc.'s business segments — internal personnel costs has grown at a 1.9% compound annual growth rate (CAGR), from $75.66M to $80.09M.
- What does business segments — internal personnel costs mean?
- This metric represents the compensation and benefits expenses for internal staff dedicated to research and development activities. It measures the company's investment in its internal scientific expertise and human capital necessary for drug discovery and clinical oversight.